Studying cancer in context to stop its growth
MIT spinout Kronos Bio, founded by Associate Professor Angela Koehler, studies the complex signaling networks of cancer cells to find new drug targets.
MIT spinout Kronos Bio, founded by Associate Professor Angela Koehler, studies the complex signaling networks of cancer cells to find new drug targets.
By analyzing epigenomic and gene expression changes that occur in Alzheimer’s disease, researchers identify cellular pathways that could become new drug targets.
Sixteen professors join the departments of Biology; Chemistry; Earth, Atmospheric and Planetary Sciences; Mathematics; and Physics.
In addition to turning on genes involved in cell defense, the STING protein also acts as an ion channel, allowing it to control a wide variety of immune responses.
A biotech entrepreneur, Koehler will help faculty and students launch startups and bring new products to market through the MIT Deshpande Center for Technological Innovation.
A new technology called RIBOmap can give researchers valuable insight into how protein production in animal and human tissue is altered in disease.
BioAutoMATED, an open-source, automated machine-learning platform, aims to help democratize artificial intelligence for research labs.
The first RNA-guided DNA-cutting enzyme found in eukaryotes, Fanzor could one day be harnessed to edit DNA more precisely than CRISPR/Cas systems.
MIT researchers characterize gene expression patterns for 22,500 brain vascular cells across 428 donors, revealing insights for Alzheimer’s onset and potential treatments.
By applying a language model to protein-drug interactions, researchers can quickly screen large libraries of potential drug compounds.
The Fulbright US Student Program funds opportunities for research, graduate study, and teaching abroad.
The new diagnostic, which is based on analysis of urine samples, could also be designed to reveal whether a tumor has metastasized.
With the right building blocks, machine-learning models can more accurately perform tasks like fraud detection or spam filtering.
With further development, the programmable system could be used in a range of applications including gene and cancer therapies.
Study reveals key cell structures and gene expression changes near amyloid plaques and tau tangles in mouse brain tissue.